Prolog Ventures related stories
All articles and analysis
Bunt On Base or Aim for the Fences?True VCs swing for a grand slam every time they face the pitcher, say Patrick Pohlen and Alan Mendelson of Latham & Watkins
- Advent Venture backs MetaPhore
The UK IT and life sciences investor has made its third investment in as many weeks as part of a $30m investment in the US pharmaceuticals firm.
- St. Louis Revs its Startup Engine
Once a major corporate headquarters town, the Gateway City is becoming more entrepreneurial
Betting on the FarmOutside of the virtual FarmVille, more investors are beefing up their expertise in the real life agricultural sector, laying down money on fuel, biopesticides, feed startups and more. Their gamble is paying off, too, as some are reaping exits
- VC-Backed Nexus Dx Adds Nemmers to Board
San Diego-based Nexus Dx Inc. has named Joseph Nemmers Jr. to its board of directors. Nemmers is the principal in a private consulting practice specializing in the pharmaceutical and medical device industries, and serves as an advisor to Warburg Pincus. Nexus is backed by investors including Bay City Capital, Kleiner Perkins Caufield & Byers, Prolog Ventures and Warburg Pincus.
- Warburg Pincus Buys International Technidyne For $55 Million
Private equity firm Warburg Pincus has acquired International Technidyne for $55 million in cash, and has merged the company with clinical diagnostics company Nexus Dx. International Technidyne, based in New Jersey, provides hemostasis management and point-of-care testing products. Nexus Dx is based in San Diego, Calif.
- Exit watch, week of Aug. 23, 2010
News briefs about the acquisitions of Conduit Labs, ZyStor and other VC-backed companies in the past week
- BioMarin Pharma Buys ZyStor Therapeutics
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has acquired ZyStor Therapeutics Inc., a Milwaukee-based developer of enzyme replacement therapies for the treatment of lysosomal storage diseases. The deal is valued at up to $111 million, including a $22 million up-front payment and $93 million in earn-outs. ZyStor raised $8.5 million in VC funding in 2004, from Mason Wells, Venture Investors, Prolog Ventures, State of Wisconsin Investment Board, Hexagon Investments, Apjohn Ventures and Stonehenge Capital.